Alzheimer's Disease Clinical Trials in Philadelphia

Showing 201-220 of 266 trials

Coordinating Center for Caregiver Intervention Trial

NCT00177489

The primary goal of this study is to test a single multi-component intervention among family caregivers of persons with Alzheimer's disease or related disorders. The overall objectives of study are to 1) identify and reduce modifiable risk factors among diverse family caregivers of patients with Alzheimer's Disease or a related disorder, 2) enhance the quality of care of the care recipients, and 3) enhance the well-being of the caregivers.

DementiaAlzheimer Disease

University of Pittsburgh613 participantsStarted Jun 2002

Birmingham, Alabama, United States • Menlo Park, California, United States • Miami, Florida, United States +2 more locations

COMPLETEDPhase 4< 1 mile

Evaluation of Reader Training Processes

NCT02051790

This study is designed to evaluate the agreement between florbetapir F 18 scan interpretation in the clinic and by expert readers.

Alzheimer's Disease

Avid Radiopharmaceuticals241 participantsStarted Mar 2014

Philadelphia, Pennsylvania, United States

COMPLETEDNA< 1 mile

Home-Based Assessment for Alzheimer Disease Prevention

NCT00546767

The purpose of this study is to evaluate three methods of performing home-based assessments in Alzheimer's Disease (AD) prevention trials. The initial in-person assessment will be done in the clinic or at home.

Mild Cognitive ImpairmentAlzheimer's Disease

Alzheimer's Disease Cooperative Study (ADCS)640 participantsStarted Sep 2007

Birmingham, Alabama, United States • Sun City, Arizona, United States • Irvine, California, United States +25 more locations

Coordinating Center for Caregiver Intervention Trial

Evaluation of Reader Training Processes

Home-Based Assessment for Alzheimer Disease Prevention

Alzheimer's Disease Trials in Other Cities

ADNI: Alzheimer's Disease Neuroimaging Initiative

Citalopram for Agitation in Alzheimer's Disease

Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025

Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease

Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease

Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Effect of NeuroAD on the Cognitive Function of Alzheimer Patients

DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease

A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease

Partners in Dementia Care: A Telephone Care Consultation Intervention Provided to Veterans in Partnership With Local Alzheimer's Association Chapters

Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease

Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease

QTc Study of Rosi XR in Healthy Volunteers

Other Conditions in Philadelphia